Mel J. Yeates
This person does not yet have a bio.
Articles by Mel J. Yeates
| 4 min read
The monoclonal antibodies combination therapy demonstrated superior overall survival versus platinum-based chemotherapy
| 3 min read
Researchers posit that post-infectious hydrocephalus could be preventable
| 2 min read
An “ultrapotent” compound may help treat C. difficile infections and reduce recurrence
| 3 min read
Avacta and LSTM collaborate to clinically validate saliva-based rapid coronavirus test
| 6 min read
DDN spoke with Dr. Michael Snape, chief scientific officer of AMO Pharma, to discuss drugs that target the ERK signaling cascade, and how these drugs might be able to treat a range of developmental disorders
| 3 min read
Lodo expands AI/ML capabilities and gains exclusive rights to suite of cheminformatics technologies
| 3 min read
Innovative approach for modulating cellular metabolism could treat a variety of diseases
| 3 min read
Crosslinking mass spectrometry can now use PhoX Crosslinker and TIMS/PASEF methods
| 2 min read
Handbook includes new assays for organoid culture QC, ATP metabolism and cell cycle, as well as a new chapter on kinetic immune cell assays
| 3 min read
ASC42 is an FXR agonist expected to be used alone or in combination with other Gannex drugs
| 3 min read
New research in over 20 types of tissue finds variations and correlations between different tissue types
| 3 min read
Results published in Neurology indicate that real-world data and natural history data could augment or replace placebo controls in DMD clinical trials
